Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Potassium Channel Antagonists [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
DALFAMPRIDINE	56,141	1,482	2.6%	7,813	166	55.9 yrs	73.8%
REPAGLINIDE	2,544	169	6.6%	1,517	345	71.9 yrs	45.5%
AMIFAMPRIDINE	2,424	203	8.4%	680	23	62.5 yrs	62.6%
NATEGLINIDE	183	19	10.4%	51	13	64.0 yrs	60.3%

Head-to-Head Comparisons

DALFAMPRIDINE vs REPAGLINIDE DALFAMPRIDINE vs AMIFAMPRIDINE DALFAMPRIDINE vs NATEGLINIDE REPAGLINIDE vs AMIFAMPRIDINE REPAGLINIDE vs NATEGLINIDE AMIFAMPRIDINE vs NATEGLINIDE

← Back to Potassium Channel Antagonists [MoA] Class side effects →